Events
Neuronetics, Inc. announced that Chris Thatcher, President and Chief Executive Officer, and Steve Furlong, Chief Financial Officer, will participate in the 31st Annual Piper Jaffray Healthcare Conference in New York, NY on Thursday, December 5, 2019.
Plus Therapeutics, Inc. announced that it will be participating at the upcoming 12th annual LD Micro Main Event.
Verrica Pharmaceuticals Inc. announced that Ted White, Verrica President and CEO, will participate in a fireside chat at the Piper Jaffray 31st Annual Healthcare Conference in New York, NY on Tuesday, December 3, 2019 at 11:00 a.m. ET.
Veloxis to Host Conference Call Following Asahi Kasei Group’s Announcement of a Recommended Conditional Voluntary Public Offer for Veloxis
BONE THERAPEUTICS informs its shareholders and holders of warrants and convertible bonds of the Company that an extraordinary general shareholder meeting will be held on Thursday 12 December 2019 at 10am CET, at the Company’s registered offices, rue Auguste Piccard 37, 6041 Gosselies, Belgium.
BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology, announced that it will host an investor breakfast meeting on Thursday, December 5, 2019 at the Convene Conference Center near Grand Central Terminal in New York, N.Y.
Alimera Sciences, Inc. announces that Rick Eiswirth, President and Chief Executive Officer of Alimera, will participate in the 31st Annual Piper Jaffray Healthcare Conference in New York City on December 3, 2019.
Kura Oncology, Inc. announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019 at 12:00 p.m. ET / 9:00 a.m. PT.
BeiGene, Ltd. announced that the company will present at the 31st Annual Piper Jaffray Healthcare Conference in New York, NY.
Pharma Integrates 2019, which took place on 18th and 19th November, saw over 450 delegates from biotech, pharma, CDMOs and the supply chain come together to debate and share insights on key topics currently affecting the industry.
PRESS RELEASES